April/May 2006

In this issue

Stay current with the latest news and information

Outstanding group ‘matches’ with Baylor and Texas Children’s Hospital

Osteoporosis: A disease with pediatric roots?

Watch for intraoperative awareness and notify the Department of Anesthesia

HIPAA dos and don’ts for disclosing Protected Health Information

Take note of the new Procedural Pain Protocol

Texas Children's news for the medical staff

Grand Rounds

Medical staff committees and chairs

Home

Archives


Advisors

Ralph D. Feigin, M.D.
Physician-in-Chief
Texas Children's Hospital
Professor and Chairman
Department of Pediatrics
Baylor College of Medicine

Joseph A. Garcia-Prats, M.D.
Neonatologist
Texas Children's Hospital
Professor of Pediatrics and Professor of Medical Ethics Baylor College of Medicine

Arnold G. Kagan, M.D.
Clinical Associate Professor of Pediatrics

Editor
Cindy Shanley
Marketing and Public Relations
Texas Children’s Hospital
832-824-2180

 

Diagnostic Virology
Laboratory Newsletter

 

 
 


For  members of the Texas Children's Hospital medical staff

Take note of the new Procedural Pain Protocol

The new Procedural Pain Protocol was implemented on March 14. This protocol allows nurses to use medications to prevent pain for procedures identified in the protocol automatically for each patient who enters our main campus or health centers. An order is required to exclude patients from the protocol, rather than the customary requirement of an order to allow patient participation.

The procedures are those performed by nurses: PIV access, implanted port access, venipuncture and IM injections. The medications are sucrose, LMX 4 percent lidocaine cream, LidoSite iontophoresis system delivering Lidocaine with Epinephrine, buffered lidocaine injection, and ethyl chloride spray.

This is a new expectation of children being entitled to pain prevention for these procedures. The addition of the protocol and two medications to formulary is intended to remove barriers to achieve this goal of pain prevention.
 

Procedure

Age

Recommended Analgesic

Onset

 

         PIV insertion

 

 

< 6 months

Sucrose

2 mins

BOTH Sucrose and L-M-X for procedures expected to last several minutes

30 mins

> 6 months

L-M-X

30 mins

LidoSite  (> 5 years)

10 mins

Buffered Lidocaine (> 5 kg)

Immediate


Venipuncture

< 6 months

Sucrose

2 mins

> 6 months

L-M-X

30 mins

LidoSite  (> 5 years)

10 mins


Port A Cath access

 

 

L-M-X

30 mins

Lidosite  (>  5 years)

10 mins

Ethyl Chloride Spray

Immediate


IM Injections

< 6 months

Single Injection:  Sucrose

2 mins

Multiple Injections expected to last several minutes: Sucrose and L-M-X

30 mins

> 6 months

L-M-X

30 mins

























Choice of modality should be based upon urgency of the procedure, patient age, contraindications, patient
preference, and clinician expertise.

Approved by Pharmacy and Therapeutic (P&T) Committee 1/11/06.
Implementation date: 3/14/06.
Automatic protocol-physician order required to EXCLUDE patient from protocol.
 
Back to top

 

 

  Home     |     Contact us         Terms of use       Visit Texas Children's Hospital Web site    |    © 2006 Texas Children’s Hospital